Article metrics

Download PDFPDF
4cps-009 efficacy, safety and economic impact of vedolizumab in ulcerative colitis and crohn’s disease

 

Online download statistics by month:

Online download statistics by month: March 2018 to October 2024

AbstractFullPdf
Mar 20184207
Apr 20182001
May 20181000
Jun 20181600
Jul 20181600
Aug 20181000
Sep 20181000
Oct 20182801
Nov 20181200
Dec 20181200
Jan 20191402
Feb 20191000
Mar 2019800
Apr 20192503
May 20191400
Jun 2019200
Jul 2019800
Aug 2019400
Sep 20195103
Oct 2019600
Nov 2019600
Dec 2019200
Jan 2020300
Mar 20201400
Apr 2020300
May 20201200
Jun 20201500
Jul 20201000
Aug 2020202
Sep 2020200
Oct 2020600
Nov 2020700
Dec 2020402
Jan 2021600
Feb 20211400
Mar 2021500
May 2021300
Nov 20211000
Dec 20211200
Feb 2022200
Mar 2022800
Apr 2022500
May 2022600
Jun 2022200
Jul 2022600
Aug 2022400
Sep 2022400
Oct 20221000
Nov 20221600
Dec 20221600
Jan 2023200
Feb 2023600
Mar 2023800
Apr 2023400
May 2023400
Jun 2023200
Jul 20231000
Aug 2023500
Nov 2023900
Dec 20231200
Jan 2024400
Feb 2024200
Mar 20241400
Apr 2024600
May 2024400
Jun 2024400
Jul 2024800
Aug 2024100
Sep 2024800
Oct 2024600
Total652021